Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
( 7.2 ) 7.1Concomitant Use with an Insulin Secretagogue (e.g., Sulfonylurea) or with Insulin When initiating MOUNJARO, consider reducing the dose of concomitantly administered insulin secretagogues (e.g., sulfonylureas) or insulin to reduce the risk of hypoglycemia [see Warnings and Precautions ( 5.3 )]
End of Article Related Article health-wellness Experiencing Breathlessness & Persistent Cough
Common injection sites include the abdomen, upper arms, and front of the thighs
Monthly weight loss of 5 to 10 pounds is common during this active loss phase
Patients should not use tirzepatide that appears cloudy, discolored, or contains particles, regardless of storage history
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 29.06
US$ 27.29
US$ 26.18
US$ 26.86
US$ 21.57
US$ 22.38
